In this work the efficacy of the treatment of acute tenodesmic lesions using platelet rich plasma (PRP) and autologous mesenchymal stem cells (MSCs) was studied in 17 thoroughbred racehorses. Here we describe and compare our results with data from literature concerning ultrasound controls, clinical results, the follow up, the recovery time to sport activities and the percentage of clinical success and reinjures.
Application of autologous mesenchymal stem cells (MSCs) and platelet rich plasma (PRP) for the treatment of tendon-ligament injuries in thoroughbred racehorses
Martinello T.;
2011-01-01
Abstract
In this work the efficacy of the treatment of acute tenodesmic lesions using platelet rich plasma (PRP) and autologous mesenchymal stem cells (MSCs) was studied in 17 thoroughbred racehorses. Here we describe and compare our results with data from literature concerning ultrasound controls, clinical results, the follow up, the recovery time to sport activities and the percentage of clinical success and reinjures.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
